Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: docetaxel|DRUG: pegylated liposomal doxorubicin hydrochloride|PROCEDURE: conventional surgery|PROCEDURE: neoadjuvant therapy
Sponsor: Roswell Park Cancer Institute
Collaborators: National Cancer Institute (NCI)